Insulet (PODD) Free Cash Flow (2010 - 2026)
Insulet (PODD) posted Free Cash Flow of $89.5 million for Q1 2026, up 1621.15% on a QoQ basis from $5.2 million in Q4 2025, and up 73.79% year-over-year from $51.5 million in Q1 2025.
Insulet (PODD) Free Cash Flow (2010 - 2026) Analysis & Trends
Insulet's Free Cash Flow history runs 17 years deep, the most recent figure standing at $89.5 million for Q1 2026.
- Quarterly Free Cash Flow rose 73.79% year-over-year to $89.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415.7 million (up 6.05% YoY) and the FY2025 annual result came in at $377.7 million, down 10.31% from the prior year.
- Free Cash Flow was $89.5 million for Q1 2026 at Insulet, up from $5.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $209.7 million in Q4 2024 and bottomed at -$24.2 million in Q4 2023.
- A 5-year average of $62.6 million and a median of $51.5 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow slumped 150.21% — and 2024, when it surged 966.53%.
- Insulet's Free Cash Flow stood at $48.2 million in 2022, then slumped by 150.21% to -$24.2 million in 2023, then jumped by 966.53% to $209.7 million in 2024, then slumped by 97.52% to $5.2 million in 2025, then jumped by 1621.15% to $89.5 million in 2026.
- Business Quant data shows PODD's Free Cash Flow at $89.5 million in Q1 2026, $5.2 million in Q4 2025, and $120.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Insulet | 11.61 Bn | 11.13 Bn | 529.10 Mn | 89.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.50 Mn |
| Mar 31, 2026 | 89.50 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 120.20 Mn |
| Sep 30, 2025 | 120.20 Mn |
| Jun 30, 2025 | 200.80 Mn |
| Jun 30, 2025 | 200.80 Mn |
| Mar 31, 2025 | 51.50 Mn |
| Mar 31, 2025 | 51.50 Mn |
| Dec 31, 2024 | 209.70 Mn |
| Dec 31, 2024 | 209.70 Mn |
| Sep 30, 2024 | 81.60 Mn |
| Sep 30, 2024 | 81.60 Mn |
| Jun 30, 2024 | 49.20 Mn |
| Jun 30, 2024 | 49.20 Mn |
| Mar 31, 2024 | 80.60 Mn |
| Mar 31, 2024 | 80.60 Mn |
| Dec 31, 2023 | -24.20 Mn |
| Dec 31, 2023 | -24.20 Mn |